Search
Search Results
##search.searchResults.foundPlural##
-
TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity
2299PDF: 1645HTML: 276 -
LETERMOVIR PRIMARY CYTOMEGALOVIRUS PROPHYLAXIS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS: COULD INFECTION AND DISEASE NO LONGER BE A SIGNIFICANT PROBLEM? Letermovir and Cytomegalovirus Prophylaxis in HSCT
1323PDF: 1022HTML: 125 -
Interstitial pneumonia triggered by H1N1 influenza A virus as the initial presentation of chronic myeloid leukemia
894PDF: 492HTML: 148Suppl. Files: 330 -
MANAGEMENT OF PORTAL VEIN THROMBOSIS IN CIRRHOTIC PATIENTS
829PDF: 544HTML: 4026 -
THE EMERGING RESISTANCE IN NOSOCOMIAL URINARY TRACT INFECTIONS: FROM THE PEDIATRICS PERSPECTIVE.
2132PDF: 959HTML: 196The emerging resistance in nosocomial urinary tract infections: from the pediatrics perspective: 250 -
A strange case of Malaria in a Nigerian native boy.
2457PDF: 871HTML: 1308 -
Successful Outcomes of Severe COVID-19 in Patient with Chronic Lymphocytic Leukemia: Diagnostic Challenges in Immunocompromised Hosts COVID-19 in cancer patients
1215PDF: 797HTML: 222 -
TUBERCULOSIS IN PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES
3316PDF: 1257HTML: 8123 -
-
ASSOCIATION BETWEEN PRE-ADMISSION 48-HOUR FEVER BURDEN AND OUTCOMES IN PEDIATRIC MYCOPLASMA PNEUMONIAE INFECTION PRE-ADMISSION 48-HOUR FEVER BURDEN AND OUTCOMES IN PEDIATRIC MYCOPLASMA PNEUMONIAE
181PDF: 250Suppl. Files: 40HTML: 28 -
A Case of Rupioid Syphilis Masquerading as Aggressive Cutaneous Lymphoma
2261PDF: 973HTML: 5072Cover Letter: 172Figure 2: 167Figure 1: 177Figure 3: 199Figure 4: 172Figure Legend: 190Table 1: 193Table 2: 186Table 3: 186 -
TUBERCULOSIS IN HEMATOPOIETIC STEM CELL TRANSPLANT PATIENTS.
2657PDF: 964HTML: 3645 -
Ceftolozane-Tazobatam for febrile neutropenia treatment in hematologic malignancy patients colonized by multi-resistant Enterobacteriaceae: preliminary results from a prospective cohort study Ceftolozane-Tazobatam for febrile neutropenia
7878PDF: 728HTML: 222 -
SPHINGOMONAS PAUCIMOBILIS INFECTIONS IN CHILDREN: NOSOCOMIAL VERSUS COMMUNITY ACQUIRED INFECTIONS
1800PDF: 1028HTML: 2042cover: 185Table 1. Co-morbidities associated with Sphingomonas paucimobilis infections.: 186Figure 1. The antimicrobial susceptibility patterns of Sphingomonas paucimobilis isolated from clinical specimens: 1610title page: 194 -
TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA WITH AIDA BASED REGIMEN
3976PDF: 762HTML: 1854 -
Kikuchi-Fujimoto disease and hemophagocytic lymphohistiocytosis: a rare combination of two rare diseases
850PDF: 631Suppl. Files: 124HTML: 97 -
SIMPLE PERIPHERAL BLOOD SMEAR FINDINGS OF COVID-19 PATIENTS PROVIDE INFORMATION ABOUT THE SEVERITY OF THE DISEASE AND THE DURATION OF HOSPITAL STAY. Peripheral blood smear and COVID-19 severity.
3354PDF: 1154HTML: 448 -
THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION
4154PDF: 1975HTML: 1774 -
CHILDREN IN CORONAVIRUSES’ WONDERLAND: WHAT CLINICIANS NEED TO KNOW Corona virus and Children
1465PDF: 952HTML: 409 -
TYROSINE KINASE INHIBITORS AND PREGNANCY
3646PDF: 1662HTML: 2679 -
The Outcome of Six Patients with COVID-19 Infection and Multiple Myeloma. A Case Series and Literature Review COVID-19 in Multiple Myeloma patients
1005PDF: 368HTML: 208







